These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 6357983)
1. Comparison of potency of porcine insulin and semisynthetic human insulin at 3 dose levels using the euglycaemic clamp. Chisholm DJ; Kraegen EW; Hewett MJ; Lazarus L Horm Metab Res; 1983 Sep; 15(9):415-8. PubMed ID: 6357983 [TBL] [Abstract][Full Text] [Related]
2. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers. Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effect of semisynthetic human insulin and porcine insulin on glucose kinetics, plasma free fatty acid and amino acid levels in man. Müller R; Berger W; Wick H; Keller U Horm Metab Res; 1984 Jun; 16(6):271-4. PubMed ID: 6389293 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the activity and pharmacokinetics of porcine insulin and human insulin (Novo) as assessed by the glucose clamp technique in normal and diabetic man. Home PD; Shepherd GA; Noy G; Massi-Benedetti M; Hanning I; Burrin JM; Alberti KG Diabetes Care; 1983; 6 Suppl 1():23-8. PubMed ID: 6343033 [TBL] [Abstract][Full Text] [Related]
5. Comparison of porcine insulin and human insulin (Novo) using the glucose-controlled insulin infusion system, glucose-insulin dose-response curves, and the outpatient effectiveness of human insulin (Novo) in insulin-dependent diabetes. Charles MA; Szekeres A; Staten M; Worcester B; Walsh KM Diabetes Care; 1983; 6 Suppl 1():29-34. PubMed ID: 6343034 [TBL] [Abstract][Full Text] [Related]
6. Semisynthetic human insulin: pharmacokinetics and biological potency in healthy subjects in comparison with highly purified porcine insulin. Schulz B; Stöwhas H; Becker R; Steinicke A; Besch W Exp Clin Endocrinol; 1988 Mar; 92(3):307-13. PubMed ID: 3075554 [TBL] [Abstract][Full Text] [Related]
7. Effects of single and combined infusions of human biosynthetic proinsulin and insulin on glucose metabolism and on plasma hormone concentrations in euglycaemic clamp experiments. Nauck MA; Stöckmann F; Thiery J; Ebert R; Creutzfeldt W Horm Metab Res Suppl; 1988; 18():60-7. PubMed ID: 3056814 [TBL] [Abstract][Full Text] [Related]
8. Equipotency of insulin glargine and regular human insulin on glucose disposal in healthy subjects following intravenous infusion. Scholtz HE; Pretorius SG; Wessels DH; Venter C; Potgieter MA; Becker RH Acta Diabetol; 2003 Dec; 40(4):156-62. PubMed ID: 14740274 [TBL] [Abstract][Full Text] [Related]
9. Different potencies of biosynthetic human and purified porcine insulin. Schlüter KJ; Enzmann F; Kerp L Horm Metab Res; 1983 Jun; 15(6):271-4. PubMed ID: 6347857 [TBL] [Abstract][Full Text] [Related]
10. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique. Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772 [TBL] [Abstract][Full Text] [Related]
12. Measurement of insulin sensitivity: influence of potassium supply during euglycaemic glucose clamps in healthy volunteers. Rave K; Heise T; Weyer C; Sawicki P; Heinemann L Exp Clin Endocrinol Diabetes; 1999; 107(5):313-7. PubMed ID: 10482044 [TBL] [Abstract][Full Text] [Related]
13. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. Saccà L; Sherwin R; Hendler R; Felig P J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832 [TBL] [Abstract][Full Text] [Related]
14. Different effects of human and porcine insulin on hypoglycemia-induced abnormalities of brainstem sensory function. Kern W; Born J; Kerner W; Fehm HL Clin Physiol Biochem; 1990; 8(3):122-7. PubMed ID: 2225719 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of subcutaneously administered U40 and U100 formulations of regular human insulin. Heinemann L; Chantelau EA; Starke AA Diabete Metab; 1992; 18(1):21-4. PubMed ID: 1563532 [TBL] [Abstract][Full Text] [Related]
16. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098 [TBL] [Abstract][Full Text] [Related]
17. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies. Olsson PO Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929 [TBL] [Abstract][Full Text] [Related]
18. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics. Raskin P; Fujita Y; Unger RH J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740 [TBL] [Abstract][Full Text] [Related]
19. Sequential infusions of glucose and insulin at prefixed rates: a simple method for assessing insulin sensitivity and insulin responsiveness. Heine RJ; Bilo HJ; van der Meer J; van der Veen EA Diabetes Res; 1986 Nov; 3(9):453-61. PubMed ID: 3549121 [TBL] [Abstract][Full Text] [Related]
20. A comparison of the activity and disposal of semi-synthetic human insulin and porcine insulin in normal man by the glucose clamp technique. Home PD; Massi-Benedetti M; Shepherd GA; Hanning I; Alberti KG; Owens DR Diabetologia; 1982 Jan; 22(1):41-5. PubMed ID: 7037507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]